NeuroSigma: Funding, Investors & Team (Oct 2026)
NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.
NeuroSigma has raised $1.0M across 1 funding round on record, the most recent an undisclosed round of $1.0M announced in Dec 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NeuroSigma Company Profile and Key Stats
Latest funding round on record: Dec 2025.
NeuroSigma Funding Rounds
NeuroSigma Founders and Leadership Team
No contact details are on record for this team yet.
NeuroSigma Funding Compared to Other Biotechnology Startups
NeuroSigma's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NeuroSigma in Biotechnology and Los Angeles
Companies Similar to NeuroSigma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
NeuroSigma Funding FAQs
What does NeuroSigma do?
NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.
How much funding has NeuroSigma raised?
NeuroSigma has raised $1.0M across 1 round on record. The most recent is an undisclosed round of $1.0M announced in Dec 2025.
When did NeuroSigma last raise funding?
NeuroSigma's most recent funding round on record is an undisclosed round of $1.0M, announced in Dec 2025.
Who founded NeuroSigma?
FundedIQ lists Alejandro Covalin (Founder) at NeuroSigma.
Where is NeuroSigma headquartered?
NeuroSigma is based in Los Angeles, California, United States.
How many employees does NeuroSigma have?
NeuroSigma is in the 11-50 employee band.
How does NeuroSigma's funding compare to other Biotechnology startups?
NeuroSigma's latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's NeuroSigma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeuroSigma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.